Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesErlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer
Cancer Chemotherapy and Pharmacology, 08/20/09
Wong MK et al. – For NSCLC patients with favourable clinical features, erlotinib was effective in those who had prior disease control with first–line gefitinib.
Related Articles
Highly concordant coexpression of aromatase and estrogen receptor beta in non–small cell lung cancer
Human Pathology, 10/08/09
Relevance Score: 91%
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab
Journal of Clinical Oncology, 11/12/09
Relevance Score: 90%
EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells
Molecular Cancer, 11/05/09
Relevance Score: 90%
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Relevance Score: 90%
Pathophysiologic Correlation Between 62Cu-ATSM and 18F-FDG in Lung Cancer
The Journal of Nuclear Medicine, 11/17/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term results of the international adjuvant lung cancer trial evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer
Journal of Clinical Oncology, 12/01/09
Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer
Cancer Chemotherapy and Pharmacology, 12/01/09
Comparison of the Clinical Effects of Paclitaxel and Paclitaxel plus Oxaliplatin as the Second-line Treatment of Advanced Non-small Cell Lung Cancer
Chinese Journal of Lung Cancer, 12/01/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Associations of MDM2 SNP309, Transcriptional Activity, mRNA Expression, and Survival in Stage I Non-Small-Cell Lung Cancer Patients with Wild-Type p53 Tumors
Annals of Surgical Oncology, 12/01/09
Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance status
Critical Reviews in Oncology/Hematology, 12/01/09
Long-term results of the international adjuvant lung cancer trial evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer
Journal of Clinical Oncology, 12/01/09
Sponsor
Article Search
Sponsor